Auxilium data suggests testosterone levels affect insulin resistance, sensitivity

By Elaine Rigoli

Tampa, Fla., June 12 - Auxilium Pharmaceuticals, Inc. said data obtained from patient screening of 568 men with type 2 diabetes found a general increase in insulin resistance in patients with type 2 diabetes who have low total testosterone levels, compared to type 2 diabetes patients with normal total testosterone levels.

Recent studies have highlighted the potential importance of androgen concentrations in relation to insulin sensitivity, Auxilium said in a news release.

This latest cohort analysis provides evidence of the need for additional investigation into the effects that testosterone replacement therapy has on insulin resistance, glucose regulation and progression of type 2 diabetes, the release said.

Auxilium Pharmaceuticals, located in Malvern, Pa., is a specialty pharmaceutical company with a focus on developing and marketing products for urology, sexual health and other indications within specialty markets.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.